{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Mikkipedia","title":"Three Studies, Three Different Answers on Supplements and the Brain","html":"","width":"100%","height":180,"duration":1555,"description":"Episode Summary\nA friend sent Mikki a link in a WhatsApp group — an NZ Herald article, originally published in the Washington Post, under the headline that popular supplements could harm the ageing brain. It named three: vitamin D, omega-3 and glucosamine. In this solo episode Mikki goes back to the three separate studies behind that single article and works through what each one actually found.\nAlong the way she lays out the difference between observational research and randomised controlled trials, and why healthy user bias makes supplement users hard to compare with non-users in the first place. The three studies do not point the same way: the vitamin D finding is statistically significant but amounts to about a third of a point on a 27-point scale over six years, the omega-3 signal is more substantial but runs directly against the randomised evidence from VITAL, and the glucosamine work is the most interesting of the three because it pairs experimental biology with human health records — though it concerns people who already have cognitive impairment. Mikki finishes with the questions worth asking of any study like this, and where she has landed on each supplement.\nKey Topics\nWhy the NZ Herald headline claims more than the evidence behind it can support, even though the article itself acknowledges the findings are preliminary, mostly observational and sometimes contradictory\nObservational studies versus randomised controlled trials, and why observational work is hypothesis-producing rather than conclusive\nHealthy user bias — researchers can statistically adjust for some differences between supplement users and non-users, but not for a healthy user lifestyle, and not for anything that was never measured\nThe vitamin D observational study: over 5,000 adults, average age 67.5, followed six years, showing faster decline in global cognition and executive function — but only about 0.31 points on a scale running to 27\nWhy very large databases can make clinically...","thumbnail_url":"https://img.transistorcdn.com/5uUjJw6NUZC5FWMQgLCI47ibFa6tBB2C0z8A_feCZiY/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wNjI2/NTEwMjAyMWQ2M2Iy/ZjliYjA4ZGFhMTBh/N2E2Ni5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}